Velosulin

Drug Description
font size
Discontinued Warning IconPlease Note: This brand name drug is no longer available in the US.

DRUG DESCRIPTION

Velosulin® BR is a clear solution of insulin in a phosphate buffer. The concentration of this product is 100 units of insulin per milliliter. This human insulin is structurally identical to the insulin produced by the pancreas in the human body. This structural identity is obtained by recombinant-DNA technology utilizing Saccharomyces cerevisiae (bakers' yeast) as the production organism. When a U-100 insulin syringe is used to deliver the insulin, the effect of Velosulin® BR begins approximately ½ hour after the injection. The effect lasts up to approximately 8 hours with a maximal effect between the 1 st and 3 rd hour.

The time course of action of any insulin may vary considerably in different individuals, or at different times in the same individual, or when using an external insulin infusion pump to deliver the insulin. Because of this variation, the time periods listed here should be considered as general guidelines only when using U-100 insulin syringes to deliver the insulin.

Last updated on RxList: 12/8/2004


Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:

Diabetes

Find tips and advances in treatment.